Jan. 16, 2026 A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts ...
US Supreme Court to hear 'skinny label' patent fight involving Amarin The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback